Akebia Therapeutics Inc Corporate Call Transcript

Mar 30, 2022 / 10:00PM GMT
Operator

Good day, and thank you for standing by. Welcome to Akebia Therapeutics Corporate Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to turn the conference over to your first speaker today to Mercedes Carrasco, Director of Corporate Communications. Please go ahead.

Mercedes Carrasco - Akebia Therapeutics, Inc. - Director of Corporate Communications

Thank you, and thank you for attending the Akebia conference call to discuss a recent regulatory update related to vadadustat. Please note that a press release was issued on Wednesday, March 30, detailing the regulatory update, and that release is available on the Investors section of our website. For your convenience, a replay of today's call will be available on our website shortly after we conclude.

Joining me today for today's call is John Butler, Chief Executive Officer; Dave Spellman, Chief Financial Officer; Dell Faulkingham, Chief Commercial Officer; and Dr. Steven Burke, our Head of R&D and Chief Medical

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot